Shenzhen Hepalink Pharmaceutical Group Co., Ltd. approved cash dividend (Tax included) CNY 0.350000 per 10 shares for the year 2021, at the AGM held on June 10, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.22 CNY | +0.33% | +2.56% | -21.40% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.40% | 1.67B | |
+19.62% | 43.78B | |
+20.44% | 21.89B | |
+10.86% | 14.45B | |
+13.07% | 13.63B | |
+37.46% | 11.49B | |
-8.59% | 6.85B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.06B |
- Stock Market
- Equities
- 002399 Stock
- News Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
- Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Approves Cash Dividend for the Year 2021